National Medicines Symposium 2024 speakers (L to R): Steve Waller, Professor Jennifer Martin, Professor Libby Roughead, Tegan Taylor[/caption]
This CPD activity is sponsored by Reckitt. All content is the true, accurate and independent opinion of the speakers and the views expressed are entirely their own.[/caption]
New PIM list reveals high-risk medicines for older patients
A new PIMs list unveiled medicines that could result in negative clinical outcomes, including hospitalisation and death in older patients.
Top 4 counselling points for levothyroxine, including updated CAL advice
How to dispense levothyroxine safely, from applying cautionary advisory labels to using the medicine’s new name.
COVID-19: Continued Dispensing extended to ensure supply of essential medicines
Emergency measures to allow continued access to essential medicines through the Pharmaceutical Benefits Scheme (PBS) have been extended to at least 30 June this year.
Moderna coming to a pharmacy near you
The first doses of Moderna’s COVID-19 vaccine (Spikevax) will be delivered to 1,200 community pharmacies at the end of next week.
PBS changes for prescription opioids
Changes to regulations on opioid supply in Australia came into effect this week, with new Pharmaceutical Benefits Scheme listings resulting in smaller quantities and restrictions around opioid prescribing for pain treatment.
What pharmacists need to know about oral antiviral treatments for COVID-19
The Therapeutic Goods Administration (TGA) has provisionally approved two oral antiviral treatments for COVID-19. Here’s what pharmacists need to know.
